Variant ID | 29656 |
---|---|
Entrez Gene ID | 144455 |
Gene | E2F7 (GeneCards) |
Location | hg19 12:77440061-77440061
hg38 12:77046281-77046281 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
Method | MiSeq |
Mutation(HGVS format) | NC_000012.11:g.77440061 G>A (Genome Assembly: hg19) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 133851895 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 1.7263 |
CADD Raw score (version 1.3) | 1.102364 (Deleterious) |
FATHMM raw prediction score | 0.95235 (Tolerated) |
Deleterious probability by DeFine | 0.9038 (Deleterious) |
Entrez Gene ID | 144455 (NCBI Gene) |
---|---|
Official Gene Symbol | E2F7 (GeneCards) |
Number of variants in E2F7 in this database | 12 (view all the variants) |
Full name | E2F transcription factor 7 |
Band | 12q21.2 |
Other IDs | Vega: OTTHUMG00000169969 OMIM: 612046 HGNC: HGNC:23820 Ensembl: ENSG00000165891 |
Other names | None |
Summary | E2F transcription factors, such as E2F7, play an essential role in the regulation of cell cycle progression (Di Stefano et al., 2003 [PubMed 14633988]).[supplied by OMIM, May 2008] |
Individual ID | 28714951.332 (view all the variants in this individual) |
---|---|
Pubmed ID | 28714951 |
Whose mosaic mutation | Patient |
Phenotype | 3 |
Disease | Autism Spectrum Disorders (view all the variants in this disease) |
OMIM ID | 209850 |
Pubmed ID | 28714951 |
---|---|
Title | Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder |
Journal | Nat Neurosci |
Publication date | 2017.07 |
Disease | Autism Spectrum Disorders |
Incidence | 0.01 |
Number of cases | cases of unknown sex: 376; |